7Arif B, Ferhan K. Recombinant human erythropoietin therapy in low-birthweight preterm infants: a prospective controlled study [J]. Pediatr Int, 2005, 47(1) :67-71.
8Juul SE, Anderson DK, Li Y, Christensen RD. Erythropoietin and erythropoietin receptor in the developing human central nervous system[ J]. Pediatr Res, 1998, 43 ( 1 ) :4049.
9Kutnral A,Ozer E, Yilmaz O, Akhisaroglu M, Gokmen N,Duman N, et al. Neuroprotective effect of erythropoietin on hypoxic-ischemic brain injury in neonatal rats [ J ]. Biol Neonate, 2003, 83 (3) : 224-228.
10McPherson R J, Juul SE. Recent trends in erythropoietin-mediated neuroprotection [ J ]. Int J Dev Neurosci, 2008, 26 ( 1 ) : 103-111.
6Taylor TA, Kennedy KA. Randomized trial of iron supple- mentation versus routine iron intake in VLBW infants[J]. Pediatrics, 2013,131(2) : e433-e438.
7Freise K J, Widness JA, Veng-Pedersen P. Erythropoietic re- sponse to endogenous erythropoietin in premature very low birth weight infants[J]. Journal of Pharmacology and Ex- perimental Therapeutics, 2010,332( 1 ) : 229-237.
8Jeon GW, Sin JB. Risk factors of transfusion in anemia of very low birth weight inIants[J]. Yonsei Medical Journal, 2013,54(2) : 366-373,.
9Rabe H ,Diaz-Rossello JL, Duley L, et al. Effect of timing of umbilical cord clamping and other strategies to influence pla- cental transfusion at preterm birth on maternal and infant outcomes[J]. Cochrane Database Syst Rev , 2012,8 : 1-84.
10Ranjit T,Nesargi S,Rao PNS,etal. Effect of early versus de- layed cord clamping on hematological status of preterm in- fants at 6 wk of age[EB/OL]. The Indian Journal of Pedi- atrics, 2014. http://link, springer, com/article/.
